nothing good is priced in - in fact, i think a lot of bad
nothing good is priced in - in fact, i think a lot of bad potential outcomes are "priced in".
i thought about this some today. right now our total market cap (company value) is $574MM. most biotechs trade for a multiple of revenue in the 6X range. So right now, the market is giving us credit for doing about $100MM in total revenue. Put another way, this company is being valued as if it will not produce meaningful revenue in the intermediate term or even longer term, as valuations are discounted back from the future to current day.
But $100MM in revenue doesn't make sense. So the real question is, is the company now being valued on the salvage value of the molecule - ie. that it won't survive as a going concern, but rather will be sold based on whatever someone will pay for Leronlimab.
Don't shoot the messenger here. I'm just trying to make sense of a total market cap of $574MM for a company with potential markets in the $10 Billion + range. It makes no sense - unless you bake in the assumption that some people are making that we'll never see those revenues.
I remain long, and have been adding here. I'm just trying to figure out what on earth is going on here, and why this thing has gotten pounded into the earth week after week, month after month. Management needs to help out the long-suffering shareholders and get themselves (and us) some sort of lifeline. They may believe they have a miracle drug (and many of us also believe that) but they also need to realize that we're in a world of #$%^ right now with regard to this investment.
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Advenica's Ascent in Secure File Transfer The cybersecurity world never sleeps, and with the rapid pace of digital threats, it's no surprise that secure file transfer solutions are becoming hotter commodities than coffee pots on Wall Street. Advenica, a name that might not ring a bell for everyone, has emerged as an 'Emerging Leader' in MarketsandMarkets' latest...
Continue Reading
KuCoin's Bold Move with KCUSD Folks, the cat's outta the bag with KuCoin's latest maneuver—introducing KCUSD. At first glance, it seems like they're just introducing another fancy stablecoin product, but peel the onion and there's more to it. We're talking about shaking up how stablecoins sit tight doing nada in the crypto world. KCUSD is out to make those idle balances...
Continue Reading
A New Chapter in Industrial Decarbonization Today's not just your average ribbon-cutting ceremony; it's a landmark turn in our journey toward a cleaner Europe. Yara's Sluiskil plant in the Netherlands just fired up Europe's biggest carbon capture facility, marking a crucial pivot point in industrial decarbonization. We're talking about capturing a staggering 800,000 tons...
Continue Reading
Smarter Energy Systems Are Here Gone are the days when solar inverters were just clunky bits of tech you threw on a roof. Sungrow's latest MGTL Series, revealed in Da Nang, marks a revolutionary step for Southeast Asia, Africa, Latin America, and beyond. They're not just talking the talk—they're bringing real innovation to the table. Why the MGTL Series Stands Out Look,...
Continue Reading
Snack Bars Navigate a Transforming Market There's a headwind in the snack bars market as it looks to lift off from $21.94 billion and land at $32.66 billion by 2031. That's a solid climb at an 8.28% CAGR. What's fueling this leap? A desire for convenient, portable nutrition that's squeezing into every nook of modern life—from the gym to the car, to your kid's lunchbox....
Continue Reading
Weather's Wrath and the Michigan Roof Here's the deal: Michigan doesn't mess around when it comes to weather. We're talking harsh winters with piles of snow, followed by muggy summers that toss storms like they're confetti. Keeping that roof in top shape isn't just some luxury; it’s a downright necessity. Gut-punch reality? Many ignore it until it's too late. That's...
Continue Reading
Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...
Continue Reading
When Pricing Sends the Wrong Message Jump into the high stakes poker game of Atlanta's luxury real estate, and you'll find that pricing strategy is your make-or-break move. Jud Whitlock, a seasoned veteran over at Atlanta Fine Homes/Sotheby's International Realty, lays it all down: in this digital age, pricing too high is akin to waving a red flag at savvy buyers armed...
Continue Reading
It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...
Continue Reading
DNOW's Rough Patch: Investors, Beware Here's a tangled mess for you: DNOW Inc., a name that should've been cruising post-merger, now finds itself smack in the middle of a class action lawsuit. Blame it on some botched acquisition moves with MRC Global Inc. The suits claim DNOW's management may have played fast and loose with the truth during their big merger spiel. When...
Continue Reading
Top 5 Most Recently Viewed Articles
Investing in Semler Scientific, Inc. (NASDAQ: SMLR) Investors in Semler Scientific, Inc. have found themselves at a crucial crossroads as the company faces significant allegations regarding securities fraud. This situation presents an opportunity for investors to consider what steps they can take to safeguard their investments and potentially recover losses incurred....
Continue Reading
Flywire Corporation to Attend Major Investor Conference Flywire Corporation (NASDAQ: FLYW) has recently announced its participation in the highly anticipated UBS Global Tech and AI Conference. The event will take place in Phoenix, Arizona. The Company's session is scheduled for 7:35 am MST, where they will engage in an insightful fireside chat. Webcast and Replay Details...
Continue Reading
Nuance Pharma Expands Distribution for Bentrio Nasal Spray Nuance Pharma is making significant strides by enhancing its exclusive license and distribution agreement with Altamira Medica Ltd. This updated contract now extends coverage to seven additional countries in East and Southeast Asia. The announcement was made by Altamira Therapeutics Ltd. (NASDAQ: CYTO), the parent...
Continue Reading
Investor Alert: Ongoing Investigation into Crocs Holdings Faruqi & Faruqi, LLP is actively investigating the financial practices of Crocs, Inc. (NASDAQ: CROX) amidst mounting concerns over the company's revenue reporting and overall operations. For investors holding substantial stakes in Crocs, understanding the implications of this investigation is crucial for protecting...
Continue Reading
Strategic Appointments Propel VIS-101 Forward In an exciting development for VIS-101, NovaBridge Biosciences has appointed two distinguished leaders in ophthalmology, Cadmus C. Rich, MD, MBA, as Chief Medical Officer and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board. Their expertise will significantly enhance the clinical development of this...
Continue Reading